Search Site

Trends banner

King Salman

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

Alphabet posts first $100 bn quarter

The growth was powered by cloud division buoyed by AI
  • Saudi king treated for lung infection: statement

    Riyadh, Saudi Arabia - Saudi Arabia's King Salman has a lung infection and is undergoing a treatment programme involving antibiotics, the Royal Court said Sunday in the latest update on the ageing monarch's health. Earlier in the day, the court said King Salman was suffering from "high temperature" and joint pain,...